Martin Smith

The dopamine D3-receptor: A postsynaptic receptor inhibitory on rat locomotor activity

Nicholas Waters, Kjell Svensson, Susanne R. Haadsma‐Svensson et al. · Journal of Neural Transmission · 1993 · 256 citations

Health Sciences, Postsynaptic Receptor Inhibitory, Functional Selectivity +14

Inhibition of dopamine neuron firing by pramipexole, a dopamine D3 receptor-preferring agonist: comparison to other dopamine receptor agonists

Montford F. Piercey, William E. Hoffmann, Martin Smith et al. · European Journal of Pharmacology · 1996 · 164 citations

Medicine, Neuropeptide Receptor, Neuropharmacology +8

Vigabatrin with hormonal treatment versus hormonal treatment alone (ICISS) for infantile spasms: 18-month outcomes of an open-label, randomised controlled trial

Finbar O’Callaghan, Stuart W. Edwards, Fabienne Dietrich Alber et al. · The Lancet Child & Adolescent Health · 2018 · 161 citations · Full text

Pain Disorders, Hormonal Treatment, Pediatrics +6

substituted (S)-Phenylpiperidines and Rigid Congeners as Preferential Dopamine Autoreceptor Antagonists: Synthesis and Structure-Activity Relationships

Clas Sonesson, Chiu‐Hong Lin, Lars O. Hansson et al. · Journal of Medicinal Chemistry · 1994 · 115 citations · Full text

Molecular Pharmacology, Central Dopamine, Biochemistry +15

(<i>S</i>)-(−)-4-[4-[2-(Isochroman-1-yl)ethyl]piperazin-1-yl]benzenesulfonamide, a Selective Dopamine D₄ Antagonist

Ruth E. TenBrink, Carol L. Bergh, J. Neil Duncan et al. · Journal of Medicinal Chemistry · 1996 · 98 citations · Full text

Molecular Pharmacology, Medicinal Chemistry, Medicine +12